Foundation for Mitochondrial Medicine

AA

A A
Foundation for Mitochondrial Medicine

Stealth BioTherapeutics MMPOWER-2 Press Release


 

Stealth BioTherapeutics MMPOWER-2 Press Release

 

Stealth BioTherapeutics will present top-line data from their MMPOWER-2 Phase 2 continuation trial at the United Mitochondrial Disease Foundation (UMDF) Mitochondrial Medicine Symposium on Thursday, June 29, in Washington, DC at 8:00 a.m. EDT.

In attendance will be Laura Stanley, FMM Executive Director, who will report back to the FMM community. FMM has been watching with excitement as this first-of-its-kind Primary Mitochondrial Myopathy Trial has been unfolding.

To read the press release, click the link below:

http://www.prnewswire.com/news-releases/stealth-biotherapeutics-to-present-top-line-data-from-mmpower-2-phase-2-continuation-trial-at-mitochondrial-medicine-symposium-2017-300474287.html?tc=eml_cleartime

 

Stay Connected with FMM

  • This field is for validation purposes and should be left unchanged.
Translate »